Skip to main content
Carna Biosciences, Inc. logo

Carna Biosciences, Inc. — Investor Relations & Filings

Ticker · 4572 ISIN · JP3220550002 T Manufacturing
Filings indexed 77 across all filing types
Latest filing 2019-11-11 Interim / Quarterly Rep…
Country JP Japan
Listing T 4572

About Carna Biosciences, Inc.

https://www.carnabio.com/

Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.

Recent filings

Filing Released Lang Actions
四半期報告書-第17期第3四半期(2019/07/01-2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kinki Finance Bureau in Japan, as indicated by the header '【提出書類】 四半期報告書'. It covers the third quarter of the 17th fiscal period (2019-07-01 to 2019-09-30). It contains comprehensive financial statements, management analysis (MDA), and detailed corporate information. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim/Quarterly Report (IR). 9M 2019
2019-11-11 Japanese
四半期報告書-第17期第2四半期(2019/04/01-2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Carna Biosciences, Inc. in Japan. It contains detailed financial statements, management analysis (MDA), and corporate information for the second quarter of the fiscal year 2019. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Japanese
四半期報告書-第17期第1四半期(2019/01/01-2019/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kinki Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet and management's analysis of financial results for the first quarter of the 17th fiscal period (January 1, 2019, to March 31, 2019). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-14 Japanese
有価証券報告書-第16期(平成30年1月1日-平成30年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It includes a fiscal year period (平成30年1月1日 to 平成30年12月31日), financial indicators, and is filed with the Kinki Finance Bureau. It contains comprehensive financial statements and management data, confirming it is an annual report rather than an announcement. FY 2018
2019-03-27 Japanese
四半期報告書-第16期第3四半期(2018/07/01-2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kinki Local Finance Bureau in Japan, as indicated by the header and the regulatory reference to the Financial Instruments and Exchange Act. It contains detailed financial statements, including the consolidated balance sheet and income statement for the third quarter of the 16th fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-12 Japanese
四半期報告書-第16期第2四半期(2018/04/01-2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and management analysis for the second quarter of the 16th fiscal period. It is a formal, substantive financial report rather than an announcement or certification, fitting the definition of an Interim/Quarterly Report (IR). Q2 2018
2018-08-07 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.